Articles with "sf3b1 mutant" as a keyword



Photo by sharonmccutcheon from unsplash

SF3B1 mutant-induced missplicing of MAP3K7 causes anemia in myelodysplastic syndromes

Sign Up to like & get
recommendations!
Published in 2021 at "Proceedings of the National Academy of Sciences of the United States of America"

DOI: 10.1073/pnas.2111703119

Abstract: Significance Myelodysplastic syndromes (MDS) are the most commonly diagnosed malignancy of the elderly in the United States, but what causes severe anemia in MDS has been unknown. Our findings provide a detailed mechanism underlying the… read more here.

Keywords: differentiation; sf3b1 mutant; mds patients; map3k7 ... See more keywords
Photo by igorkon from unsplash

Dependency of Spliceosomal Mutant MDS on Innate Immune Signaling

Sign Up to like & get
recommendations!
Published in 2018 at "Blood"

DOI: 10.1182/blood-2018-99-111552

Abstract: Mutations in genes encoding RNA splicing factors constitute the most common class of genetic alterations in patients with myelodysplastic syndromes (MDS). These occur as heterozygous point mutations at specific amino acid residues in SF3B1, SRSF2,… read more here.

Keywords: sf3b1; map3k7; figure; sf3b1 mutant ... See more keywords
Photo from wikipedia

Coordinated Mis-Splicing of Multiple Mitochondrial Iron Metabolism Genes Causes Ring Sideroblast Formation in SF3B1-Mutant MDS

Sign Up to like & get
recommendations!
Published in 2020 at "Blood"

DOI: 10.1182/blood-2020-140817

Abstract: Splicing is a fundamental process by which introns are removed from primary RNA transcripts. Alternative splicing is a major mechanism of gene regulation by which eukaryotic cells expand their transcriptional repertoire. By contrast, aberrant splicing… read more here.

Keywords: sf3b1; formation; sf3b1 mutant; mutant sf3b1 ... See more keywords
Photo by bermixstudio from unsplash

Validation of the International Working Group Proposal for SF3B1 Mutant Myelodysplastic Syndromes.

Sign Up to like & get
recommendations!
Published in 2021 at "Blood"

DOI: 10.1182/blood.2021010831

Abstract: Komrokji et al examined the proposed international working group proposal to designate SF3B1-mutant myelodysplastic syndrome (MDS) as a unique disease entity, using a single-institution validation cohort of 1779 MDS patients, of whom 320 harbored SF3B1… read more here.

Keywords: mutant myelodysplastic; working group; international working; sf3b1 mutant ... See more keywords